1210 related articles for article (PubMed ID: 33567255)
21. SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity.
Gori Savellini G; Anichini G; Gandolfo C; Cusi MG
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452305
[TBL] [Abstract][Full Text] [Related]
22. Multiple E3 ligases act as antiviral factors against SARS-CoV-2 via inducing the ubiquitination and degradation of ORF9b.
Yu M; Li J; Gao W; Li Z; Zhang W
J Virol; 2024 Jun; 98(6):e0162423. PubMed ID: 38709105
[TBL] [Abstract][Full Text] [Related]
23. The Andes Orthohantavirus NSs Protein Antagonizes the Type I Interferon Response by Inhibiting MAVS Signaling.
Vera-Otarola J; Solis L; Lowy F; Olguín V; Angulo J; Pino K; Tischler ND; Otth C; Padula P; López-Lastra M
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321811
[TBL] [Abstract][Full Text] [Related]
24. DDIT3 Targets Innate Immunity via the DDIT3-OTUD1-MAVS Pathway To Promote Bovine Viral Diarrhea Virus Replication.
Wang S; Hou P; Pan W; He W; He DC; Wang H; He H
J Virol; 2021 Feb; 95(6):. PubMed ID: 33361422
[TBL] [Abstract][Full Text] [Related]
25. Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets.
Yang Y; Ye F; Zhu N; Wang W; Deng Y; Zhao Z; Tan W
Sci Rep; 2015 Dec; 5():17554. PubMed ID: 26631542
[TBL] [Abstract][Full Text] [Related]
26. Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling.
Sun L; Xing Y; Chen X; Zheng Y; Yang Y; Nichols DB; Clementz MA; Banach BS; Li K; Baker SC; Chen Z
PLoS One; 2012; 7(2):e30802. PubMed ID: 22312431
[TBL] [Abstract][Full Text] [Related]
27. Swine Acute Diarrhea Syndrome Coronavirus Nucleocapsid Protein Antagonizes Interferon-
Zhou Z; Sun Y; Xu J; Tang X; Zhou L; Li Q; Lan T; Ma J
Front Immunol; 2021; 12():573078. PubMed ID: 33692778
[TBL] [Abstract][Full Text] [Related]
28. TRAF5 is a downstream target of MAVS in antiviral innate immune signaling.
Tang ED; Wang CY
PLoS One; 2010 Feb; 5(2):e9172. PubMed ID: 20161788
[TBL] [Abstract][Full Text] [Related]
29. The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination.
Hu Y; Li W; Gao T; Cui Y; Jin Y; Li P; Ma Q; Liu X; Cao C
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148787
[TBL] [Abstract][Full Text] [Related]
30. Evolution of enhanced innate immune evasion by SARS-CoV-2.
Thorne LG; Bouhaddou M; Reuschl AK; Zuliani-Alvarez L; Polacco B; Pelin A; Batra J; Whelan MVX; Hosmillo M; Fossati A; Ragazzini R; Jungreis I; Ummadi M; Rojc A; Turner J; Bischof ML; Obernier K; Braberg H; Soucheray M; Richards A; Chen KH; Harjai B; Memon D; Hiatt J; Rosales R; McGovern BL; Jahun A; Fabius JM; White K; Goodfellow IG; Takeuchi Y; Bonfanti P; Shokat K; Jura N; Verba K; Noursadeghi M; Beltrao P; Kellis M; Swaney DL; García-Sastre A; Jolly C; Towers GJ; Krogan NJ
Nature; 2022 Feb; 602(7897):487-495. PubMed ID: 34942634
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation.
Wang W; Zhou Z; Xiao X; Tian Z; Dong X; Wang C; Li L; Ren L; Lei X; Xiang Z; Wang J
Cell Mol Immunol; 2021 Apr; 18(4):945-953. PubMed ID: 33637958
[TBL] [Abstract][Full Text] [Related]
32. Differential roles of RIG-I like receptors in SARS-CoV-2 infection.
Yang DM; Geng TT; Harrison AG; Wang PH
Mil Med Res; 2021 Sep; 8(1):49. PubMed ID: 34488908
[TBL] [Abstract][Full Text] [Related]
33. Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection.
Han K; Blair RV; Iwanaga N; Liu F; Russell-Lodrigue KE; Qin Z; Midkiff CC; Golden NA; Doyle-Meyers LA; Kabir ME; Chandler KE; Cutrera KL; Ren M; Monjure CJ; Lehmicke G; Fischer T; Beddingfield B; Wanek AG; Birnbaum A; Maness NJ; Roy CJ; Datta PK; Rappaport J; Kolls JK; Qin X
Am J Respir Cell Mol Biol; 2021 Jan; 64(1):79-88. PubMed ID: 32991819
[TBL] [Abstract][Full Text] [Related]
34. SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog.
Chen J; Li Z; Guo J; Xu S; Zhou J; Chen Q; Tong X; Wang D; Peng G; Fang L; Xiao S
J Virol; 2022 Apr; 96(8):e0003722. PubMed ID: 35389264
[TBL] [Abstract][Full Text] [Related]
35. Papain-like protease of SARS-CoV-2 inhibits RLR signaling in a deubiquitination-dependent and deubiquitination-independent manner.
Ran XH; Zhu JW; Chen YY; Ni RZ; Mu D
Front Immunol; 2022; 13():947272. PubMed ID: 36032116
[TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2 Nsp8 suppresses MDA5 antiviral immune responses by impairing TRIM4-mediated K63-linked polyubiquitination.
Zhang X; Yang Z; Pan T; Sun Q; Chen Q; Wang PH; Li X; Kuang E
PLoS Pathog; 2023 Nov; 19(11):e1011792. PubMed ID: 37956198
[TBL] [Abstract][Full Text] [Related]
37. MAVS activates TBK1 and IKKε through TRAFs in NEMO dependent and independent manner.
Fang R; Jiang Q; Zhou X; Wang C; Guan Y; Tao J; Xi J; Feng JM; Jiang Z
PLoS Pathog; 2017 Nov; 13(11):e1006720. PubMed ID: 29125880
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 Membrane Protein Inhibits Type I Interferon Production Through Ubiquitin-Mediated Degradation of TBK1.
Sui L; Zhao Y; Wang W; Wu P; Wang Z; Yu Y; Hou Z; Tan G; Liu Q
Front Immunol; 2021; 12():662989. PubMed ID: 34084167
[TBL] [Abstract][Full Text] [Related]
39. The Interaction between SARS-CoV-2 Nucleocapsid Protein and UBC9 Inhibits MAVS Ubiquitination by Enhancing Its SUMOylation.
Huang C; Yin Y; Pan P; Huang Y; Chen S; Chen J; Wang J; Xu G; Tao X; Xiao X; Li J; Yang J; Jin Z; Li B; Tong Z; Du W; Liu L; Liu Z
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140545
[TBL] [Abstract][Full Text] [Related]
40. SARS-CoV-2 Spike Antagonizes Innate Antiviral Immunity by Targeting Interferon Regulatory Factor 3.
Freitas RS; Crum TF; Parvatiyar K
Front Cell Infect Microbiol; 2021; 11():789462. PubMed ID: 35083167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
